financenews

Important Shareholder Update: Pomerantz Law Firm Reminds Investors of Class Action Lawsuit and Upcoming Deadlines for Xiao-i Corporation Losses

Uncovering the Truth: The Xiao-I Corporation Class Action Lawsuit A Closer Look at the Allegations In a recent development, Pomerantz LLP has filed a class action lawsuit against Xiao-I Corporation (“Xiao-I” or the “Company”) and certain officers and directors. The lawsuit, filed in the United States District Court for the Southern District of New York,…

Read More

Astrana Health’s Exciting Acquisition: Bringing Together Businesses and Assets of Prospect Health System

Exciting News in the Healthcare Industry Astrana Health, Inc. Acquires Prospect Health ALHAMBRA, Calif. , Nov. 8, 2024 /PRNewswire/ — Astrana Health, Inc. (“Astrana,” and together with its subsidiaries and affiliated entities, the “Company”) (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced…

Read More

Breaking News: Moderna’s RSV Vaccine Approved by Health Canada for Adults 60+!

mRESVIA: Moderna’s Next Breakthrough in Canada Introduction mRESVIA is Moderna’s second approved product in Canada, marking a significant milestone in the battle against respiratory syncytial virus (RSV). As the first mRNA vaccine approved for RSV and the only one available in single-dose pre-filled syringes, mRESVIA represents a major advancement in vaccine technology. Canada joins the…

Read More

Unlocking the Future: A Recap of Allogene Therapeutics Inc.’s Q3 2024 Earnings Call

Welcome to Allogene Therapeutics’ Q3 2024 Conference Call Introduction On November 7, 2024, Allogene Therapeutics, Inc. (NASDAQ: ALLO) held its Third Quarter 2024 Conference Call, where key members of the company’s leadership team shared updates on the company’s performance and discussed future plans. The call was attended by several industry analysts and investors eager to…

Read More